ClinicalTrials.Veeva

Menu

Safety Study of Univers® Revers Shoulder Prosthesis

S

Schulthess Klinik

Status

Completed

Conditions

Rotator Cuff Tear Arthropathy

Treatments

Device: Universe Reverse Prosthesis

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01778777
UniversRevers

Details and patient eligibility

About

The primary safety objective is to demonstrate that severe device-related complication (Serious Adverse Device Effect = SADE) occur within 2 years after prosthesis implantation at a rate of less than 2%. Such adverse events include (but are not limited to) revisions due to dislocation or glenoid loosening, septic arthritis and scapular fractures requiring surgical repair.

Full description

Reverse shoulder arthroplasty and its principles are still recognized today as the gold standard for treatment of degenerative arthropathy of the shoulder associated with an irreparable tear of the rotator cuff. The new Arthrex Univers® Revers Shoulder Prosthesis shows a large and narrow range of components, whether it is a stem, cup, spacer, inlay or glenosphere. Adjustment can be done in very small steps to match anatomic and biomechanic needs. The Arthrex Univers Revers Shoulder Prosthesis is the only device up to date that can be configured in two different inclination angles without any limitation in component use.

This multicentre case-series has the goal to evaluate whether patients with rotator cuff tear arthropathy benefit from the Univers® Revers shoulder prosthesis in terms of low complication risk, as well as high function and quality of life.

Enrollment

166 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged 18 years and over
  • Patient with primary omarthrosis or secondary osteoarthritis associated with insufficiency in the centering function of the rotator cuff

and

• Willing and able to give written informed consent to participate in the study including all follow-up examinations

Exclusion criteria

  • Previous ipsilateral shoulder arthroplasty
  • Acute shoulder trauma
  • Post-traumatic secondary osteoarthritis
  • Rheumatoid arthritis
  • General medical contraindication to surgery
  • Known hypersensitivity to the materials used
  • Tumour / malignoma
  • Any disease process that would preclude accurate evaluation (e.g. neuromuscular, psychiatric or metabolic disorder)
  • Bacterial infection at the time point of operation
  • Recent history of substance abuse
  • Legal incompetence
  • Pregnancy or
  • Participation in any other medical device or medicinal product study within the previous months that could influence the results of the present study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

166 participants in 1 patient group

UniverseReverse
Experimental group
Description:
Cohort get an universe reverse prosthesis
Treatment:
Device: Universe Reverse Prosthesis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems